SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019193
Filing Date
2023-11-17
Accepted
2023-11-17 16:05:26
Documents
16
Period of Report
2023-11-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sngx-20231116x8k.htm   iXBRL 8-K 36149
2 EX-99.1 sngx-20231116xex99d1.htm EX-99.1 20443
3 GRAPHIC sngx-20231116xex99d1001.jpg GRAPHIC 14345
  Complete submission text file 0001558370-23-019193.txt   298191

Data Files

Seq Description Document Type Size
4 EX-101.SCH sngx-20231116.xsd EX-101.SCH 4055
5 EX-101.DEF sngx-20231116_def.xml EX-101.DEF 3495
6 EX-101.LAB sngx-20231116_lab.xml EX-101.LAB 635
7 EX-101.PRE sngx-20231116_pre.xml EX-101.PRE 10411
10 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20231116x8k_htm.xml XML 4890
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 231418586
SIC: 2834 Pharmaceutical Preparations